Summary
Adjunctive treatment with acarbose (possibly together with sulphonylurea or insulin treatment) can be effectively utilised to achieve blood glucose control if postprandial hyperglycaemia is a problem and cannot be sufficiently controlled by dietary modifications. The α-glucosidase inhibitor, acarbose, should be taken with meals that are rich in complex carbohydrates and low in simple sugars, as recommended by diabetes associations, to achieve the greatest possible benefit from treatment
Similar content being viewed by others
References
Alberti KGMM, Gries FA, European NIDDM Policy Group. Management of non-insulin-dependent diabetes mellitus in Europe: a consensus view. Diabetic Medicine 5: 275–281, 1988
American Diabetes Association. Nutritional recommendations and principles for individuals with diabetes mellitus (1986 Position Statement). Diabetes Care 10: 126–132, 1987
American Diabetes Association. Physician’s guide to non-insulin-dependent (type II) diabetes, 2nd ed., pp. 26–34, ADA, Alexandria, 1988a
American Diabetes Association. Physician’s guide to insulin-dependent (type 1) diabetes, 2nd ed., pp. 46–53, ADA, Alexandria, 1988b
Beyer J, Schulz G, Jager H, Krause U, Cordes U. Improvement of carbohydrate tolerance in insulin dependent diabetics after administration of an α-glucosidase inhibitor demonstrated by artificial pancreas. In Creutzfeldt W (Ed.) Acarbose: effect on carbohydrate and fat metabolism, pp. 451–454, Excerpta Medica, Amsterdam, 1981
Caspary WF. Sucrose-malabsorption in man after ingestion of α-glucosidase hydrolase inhibitor. Lancet 1: 1231–1233, 1978
Caspary WF. Inhibitors influencing carbohydrate absorption. In Creutzfeldt W, Lefèbvre P (Eds) Diabetes mellitus, patho-physiology and therapy, pp. 172–191, Springer, New York, 1989
Clissold SP, Edwards C. Acarbose, a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 35: 214–243, 1988
Coulston AM, Hollenbeck CB, Swislocki AM, Reaven GM. Effect of source of dietary carbohydrate on plasma glucose and insulin response to mixed meals in subjects with NIDDM. Diabetes Care 10: 395–400, 1987
Diabetes and Nutrition Study Group of the European Association for the Study of Diabetes: statement. Nutritional recommendations for individuals with diabetes mellitus. Diabetes, Nutrition and Metabolism. Clinical and Experimental 1: 145–149, 1988
Elsenhaus B, Caspary WF. Absorption of carbohydrates. In Caspary WF (Ed.) Structure and function of the small intestine, pp. 139–163, Excerpta Medica, Amsterdam, 1987
European NIDDM Policy Group. A desktop guide for the management of non-insulin-dependent diabetes mellitus (NIDDM). IDF Bulletin 35 (Suppl.): 1–23, 1990
Gérard J, Luyckx AS, Lefèbvre P. Improvement of metabolic control in insulin dependent diabetes treated with the alphaglucosidase inhibitor acarbose for two months. Diabetologia 21: 446–457, 1981
Hanefeld M, Fischer S, Schulze J, Spengler M, Wargenau M, et al. Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone. Diabetes Care 14: 732–739, 1991
Jenkins DJA, Jenkins AL, Wolever TMS, Vuksan V, Wong GS, et al. Aims of diet in diabetes management. In Creutzfeldt W, Lefèbvre P (Eds) Diabetes mellitus: pathophysiology and therapy, Springer, New York, 1988
Leonardt W, Hanefeld M, Fischer S, Schultz J, Spengler M. Beneficial effects on serum lipids in non insulin dependent diabetics by acarbose treatment. Arzneimittel-Forshung 41: 735–738, 1991
Mann JI. Simple sugars and diabetes. Diabetic Medicine 4: 135–139, 1987
Müller L. Chemistry, biochemistry and therapeutic potential of microbial α-glucosidase inhibitors. In Demain et al. (Eds) Novel microbial products for medicine and agriculture, pp. 109-166, Society for Industrial Microbiology, 1989
Puls W, Bischoff H. The pharmacological rationale of diabetes mellitus therapy with acarbose. In Creutzfeldt W (Ed.) Acarbose for the treatment of diabetes mellitus, pp. 36–38, Springer, Berlin, 1988
Puls W, Keup U, Krause HP, Müller L, Schmidt DD, et al. Pharmacology of α-glucosidase inhibitors. Frontiers of Hormone Research 7: 235–247, 1980
Raptis S, Dimitriadis G, Hadjidakis D. Acarbose treatment in insulin dependent (type 1) diabetes mellitus. In Creutzfeldt W (Ed.) Acarbose for the treatment of diabetes mellitus, pp. 141–152, Springer, New York, 1987
Riccardi G, Rivellese A, Pocioni D, Genovese S, Mastranzo P, et al. Separate influence of dietary carbohydrate and fibre on the metabolic control in diabetes. Diabetologia 26: 116–121, 1984
Sachse G. Acarbose in non-insulin-dependent diabetes. Long-term studies in combination with oral agents. In Creutzfeldt W (Ed.) Acarbose for the treatment of diabetes mellitus, pp. 92–111, Springer, New York, 1987
Stout RW. Hyperinsulinaemia — a possible risk factor for cardio-vascular disease in diabetes mellitus. Hormone and Metabolic Research 15: 37–41, 1985
Toeller M. Kohlenhydrate in der Diabeteskost. Ernährungs-Umschau 36: 363–368, 1989
Toeller M. Diabetesschulung. Internist 31: 208–217, 1990a
Toeller M. Dietary treatment and α-glucosidase inhibitors in NIDDM. Diabetes, Nutrition and Metabolism. Clinical and Experimental 3 (Suppl. 1): 43–49, 1990b
Toeller M. Diättherapie des Diabetes mellitus. Fortschritte der Medizin 2: 19–22, 1991a
Toeller M. Modulation of intestinal glucose absorption: postponement of glucose absorption by α-glucosidase inhibitors. In Mogensen CE, Standl E (Eds) Pharmacology of diabetes. Present practice and future perspectives, pp. 93–112, Walter de Gruyter, New York, 1991b
Toeller M. Inhibiteurs de l’α-gjucosidase. In Journés de diabétologie de l’Hotel-Dieu, pp. 203-212, Flammarion Médicine-Sciences, Paris, 1991c
Tuomilehto J. Acarbose monotherapy in the treatment of non-insulin-dependent diabetes mellitus: a review. In Creutzfeldt W (Ed.) Acarbose for the treatment of diabetes mellitus pp. 104–116, Springer, New York, 1987
Van Gaal L, Vansant G, De Leeuw I. Upper body adiposity and the risk for atherosclerosis. Journal of the American College of Nutrition 8: 504–514, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Toeller, M. Nutritional Recommendations for Diabetic Patients and Treatment with α-Glucosidase Inhibitors. Drugs 44 (Suppl 3), 13–20 (1992). https://doi.org/10.2165/00003495-199200443-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199200443-00003